Market Place
Sourcing Support
HealthBioAI Announces the Acceptance by FDA to Proceed with Trial for COVID/PASC
15 Feb 2024 //
PR NEWSWIRE
3 Pharms` Generic Maraviroc Receives Approval in the U.S.
17 Aug 2023 //
FDA
Hetero Labs` Generic Maraviroc Receives Approval in the U.S.
07 Feb 2022 //
FDA
IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Ph2 Clinical Trial
20 Oct 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.